Article
Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute…
ImmunoTargets and Therapy · 2023 · Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C
Key facts
| Title | Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes |
|---|---|
| First author | Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C |
| Journal | ImmunoTargets and Therapy |
| Published | Nov 23, 2023 |
| DOI | 10.2147/ITT.S429402 |
| Devices mentioned | K181380, K864267 |
| Product codes mentioned | DPM, MAX |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1